Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Planned maintenance
A system upgrade is planned for 17/11-2026, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
Catharina Hosp, Dept Surg, POB 1350, NL-5602 ZA Eindhoven, Netherlands;Univ Padua, Surg Clin 1, Dept Surg Oncol & Gastroenterol, Padua, Italy.
Catharina Hosp, Dept Surg, POB 1350, NL-5602 ZA Eindhoven, Netherlands.
Veneto Inst Oncol IOV IRCCS, Unit Surg Oncol Esophagus & Digest Tract, Castelfranco Veneto, TV, Italy.
MedStar Washington Hosp Ctr, Ctr Gastrointestinal Malignancies, 106 Irving St NW,Suite 3900, Washington, DC 20010 USA.
Show others and affiliations
2018 (English)In: European Journal of Surgical Oncology, ISSN 0748-7983, E-ISSN 1532-2157, Vol. 44, no 12, p. 1942-1948Article in journal (Refereed) Published
Abstract [en]

Background: At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study was to investigate the current worldwide practice.

Methods: HIPEC experts from 19 countries were invited through the Peritoneal Surface Oncology Group International (PSOGI) to complete an online survey concerning their personal expertise and current hospital and country wide practice.

Results: It is estimated that currently more than 3800 patients with CRC-PM (synchronous and metachronous) are annually treated with CRS and HIPEC in 430 centers. Integration of CRS and HIPEC in national guidelines varies, resulting in large treatment disparities between countries. Amongst the experts, there was general agreement on issues related to indication, surgical technique and follow up but less on systemic chemotherapy or proactive strategies.

Conclusion: This international survey demonstrates that CRS and HIPEC is now performed on a large scale for CRC-PM patients. Variation in treatment may result in heterogeneity in surgical and oncological outcomes, emphasising the necessity to reach consensus on several issues of this comprehensive procedure. Future initiatives directed at achieving an international consensus statement are needed.

Place, publisher, year, edition, pages
ELSEVIER SCI LTD , 2018. Vol. 44, no 12, p. 1942-1948
Keywords [en]
Colorectal peritoneal metastases, Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy
National Category
Surgery
Identifiers
URN: urn:nbn:se:uu:diva-373016DOI: 10.1016/j.ejso.2018.07.003ISI: 000452943200016PubMedID: 30075978OAI: oai:DiVA.org:uu-373016DiVA, id: diva2:1277504
Available from: 2019-01-10 Created: 2019-01-10 Last updated: 2019-01-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Cashin, Peter

Search in DiVA

By author/editor
Cashin, Peter
By organisation
Upper Abdominal Surgery
In the same journal
European Journal of Surgical Oncology
Surgery

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 272 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf